OTCMKTS:CMPD CompuMed (CMPD) Stock Price, News & Analysis $6.20 +0.01 (+0.16%) As of 07/1/2026 03:08 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsBuy This Stock About CompuMed Stock (OTCMKTS:CMPD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CompuMed alerts:Sign Up Key Stats Today's Range$6.05▼$6.2050-Day Range$5.85▼$6.9452-Week Range$1.95▼$6.95Volume950 shsAverage Volume553 shsMarket Capitalization$8.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults. It also offers OsteoGram software that works in combination with standard or digital X-ray equipment to support osteoporosis screening, diagnosis, and therapy monitoring. In addition, the company provides mobile ECG and ultrasound solutions that provide patients with immediate access to its board-certified specialists; and medical devices. It serves organ procurement organizations, rural healthcare, and correctional healthcare industries. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California. Read More Receive CMPD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CompuMed and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CMPD Stock News HeadlinesCMPD arrests juvenile for handgun, marijuana possessionMay 6, 2025 | yahoo.comCompuMed, Inc. (CMPD) Latest Stock News & Headlines - Yahoo FinanceMay 4, 2025 | finance.yahoo.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. | Profits Run (Ad)CMPD investigating after deadly shooting in Uptown CharlotteNovember 6, 2024 | yahoo.comCMPD to discuss theft ring caseAugust 24, 2024 | yahoo.comCompumed Inc.May 23, 2024 | wsj.comCompuMed, Inc.: CompuMed, FireStarter Collaborate to Further Shared Vision of Saving More Lives through Organ Donation and TransplantationMay 1, 2024 | finanznachrichten.deCompuMed, Inc. (CMPD) Stock Price, News, Quote & History - Yahoo FinanceApril 24, 2024 | finance.yahoo.comSee More Headlines CMPD Stock Analysis - Frequently Asked Questions How have CMPD shares performed this year? CompuMed's stock was trading at $4.4075 on January 1st, 2026. Since then, CMPD stock has increased by 40.7% and is now trading at $6.20. How were CompuMed's earnings last quarter? CompuMed Inc. (OTCMKTS:CMPD) issued its earnings results on Monday, May, 11th. The company reported ($0.06) EPS for the quarter. The company earned $2.03 million during the quarter. CompuMed had a negative trailing twelve-month return on equity of 6.47% and a negative net margin of 2.51%. When did CompuMed's stock split? CompuMed shares reverse split on the morning of Saturday, May 21st 2022.The 1-25 reverse split was announced on Saturday, May 21st 2022. The number of shares owned by shareholders was adjusted after the closing bell on Saturday, May 21st 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of CompuMed? Shares of CMPD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CompuMed own? Based on aggregate information from My MarketBeat watchlists, some other companies that CompuMed investors own include Agnico Eagle Mines (AEM). Company Calendar Last Earnings5/11/2026Today7/01/2026Fiscal Year End9/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED PRODUCTS Sub-IndustryBusiness Services Current SymbolOTCMKTS:CMPD CIKN/A Webwww.compumed.net Phone(310) 258-5000Fax310-645-5880Employees8Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$60 thousand Net Margins-2.51% Pretax Margin-2.85% Return on Equity-6.47% Return on Assets-4.18% Debt Debt-to-Equity Ratio0.12 Current Ratio2.37 Quick Ratio2.34 Sales & Book Value Annual Sales$7.55 million Price / Sales1.09 Cash Flow$0.55 per share Price / Cash Flow11.34 Book Value$2.34 per share Price / Book2.65Miscellaneous Outstanding Shares1,330,000Free Float1,037,000Market Cap$8.25 million OptionableNot Optionable Beta-0.47 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:CMPD) was last updated on 7/2/2026 by MarketBeat.com Staff. From Our PartnersUrgent exposé on the "Mar-a-Lago Trade"Dr. David Eifrig, former Goldman Sachs VP and Senior Partner at Stansberry Research, has released an urgent ex...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredWhat Happens to Your Assets If You Die Without a Will?Without a will, your state's intestacy laws decide how your assets are divided — a rigid formula that ignores ...SmartAsset | SponsoredElon Is Quietly Doubling Down on This Bizarre AssetYahoo Finance reports this technology 'May Unlock $400 Trillion' - and Bloomberg calls it 'unavoidable.' Elon ...Brownstone Research | SponsoredI paid $5,000 to hear Elon say thisOne investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...InvestorPlace | SponsoredSell Tesla, Buy the New King of FSD CarsIn 2023, Marc Chaikin's system flagged an automotive stock as bearish - and it fell 35% shortly after. Today, ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CompuMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CompuMed With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
